InVivo Therapeutics Holdings Stock
Heavy losses for InVivo Therapeutics Holdings today as the stock fell by -€0.035 (-4.450%).
With 3 Buy predictions and 2 Sell predictions the community is currently undecided on InVivo Therapeutics Holdings.
As a result the target price of €1.00 shows a positive potential of 45.349% compared to the current price of €0.69 for InVivo Therapeutics Holdings.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for InVivo Therapeutics Holdings stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of InVivo Therapeutics Holdings in the next few years
Pros
2
Could be very worthwhile Investment >20% year
Cons
0
-
Performance of InVivo Therapeutics Holdings vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| InVivo Therapeutics Holdings | -4.450% | -19.532% | -29.436% | -50.145% | 15.630% | - | - |
| Star Equity Holdings Inc. | -1.100% | -5.594% | 0.746% | 5.469% | 20.536% | -75.000% | -94.330% |
| Atossa Genetics Inc | -3.390% | -10.801% | -36.764% | 15.056% | 113.928% | -63.006% | -96.545% |
| HTG Molecular Diagnostics Inc. | -6.060% | -13.537% | -20.161% | - | - | - | - |